|
|
||||||||
Brief Communications |
1 School of Pharmacy, Memorial University of Newfoundland, St. Johns, Newfoundland, Canada
2 Department of Pharmaceutics, College of Pharmacy, University of Florida, Gainesville, Florida
3 Faculty of Medicine, Memorial University of Newfoundland, St. Johns, Newfoundland, Canada
ABSTRACT
A cholesteryl ester analog, cholesteryl 1,3-diiopanoate glyceryl ether (C2I), was synthesized and investigated for its potential use for the detection of atherosclerotic lesions in rabbits. Methods: 125I-labeled C2I was incorporated into acetylated low-density lipoprotein (AcLDL). The resultant complex, 125I-C2I-AcLDL, was injected intravenously into 2 groups of rabbits, fed cholesterol and normal chow, at a dose of 555 kBq/kg. Tissue samples were taken 24 h after injection for the biodistribution study. Atherosclerotic lesions and C2I deposition in aortic samples were examined by Sudan IV staining and autoradiography, respectively. Results: The levels of C2I in blood and aortic samples in cholesterol-fed animals were 2- to 3-fold higher than those in the control group (P < 0.05). The autoradiography results correlated well with the Sudan IV staining results, indicating sites of C2I deposition superimposed on lesion sites. Conclusion: C2I was preferentially taken up and retained at atherosclerotic lesion sites, suggesting its potential use for the detection of early atherosclerosis.
Key Words: cholesteryl 1,3-diiopanoate glyceryl ether atherosclerosis plaques acetylated low-density lipoprotein
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |